Vireo Health, a leading physician-led, science-focused multi-state cannabis company, announced on January 6 the launch of LiteBud, a patent-pending line of consistently formulated, lower-Tetrahydrocannabinol (THC) cannabis products that are designed to meet the needs of cannabis consumers seeking a more consistent, controlled and mild experience.
The first LiteBud product offering is a pre-roll made from slow-cured dry flower using a proprietary process to ensure lower levels of THC. LiteBud pre-rolls are the first product of its kind sold in Maryland’s growing medical cannabis market, currently available at dispensaries throughout the state. Later this year, Vireo plans to offer LiteBud products in other key markets in which it operates.
Read the full article here